Annual report
366A.TEDINET S100W8AL
Period2024-04-01 → 2025-03-31
Filed2025-06-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥13.3bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥10.7bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥967m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥955m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥812m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥657m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥542m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥956m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥776m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥680m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥560m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥443m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥371m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.2bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥3.9bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.7bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.7bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.1bn | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.7bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥555m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥953m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥408m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥684m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥269m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥426m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥405m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥155m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥171m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥213m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥179m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥148m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥119m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥152m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥142.47 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥124.88 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.83 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.3 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13,625.02 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥42.75 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥37.47 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30.86 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24.4 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥9,600 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥633.54 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥528.54 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥434.52 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥356.08 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥59,046.35 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 66.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.2% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 24.5% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.9% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.0% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.0% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,448,200 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 27,241 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 122 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 108 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 103 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 90 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 91 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 21
| Segment | Item | Period | Value |
|---|---|---|---|
| Health Management Cloud Businessreportable segment | employees | at 2025-03-31 | 20 pure |
| Health Management Cloud Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Health Management Cloud Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Health Management Cloud Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥722m |
| Medical Checkup Solution Businessreportable segment | employees | at 2025-03-31 | 51 pure |
| Medical Checkup Solution Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Checkup Solution Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Checkup Solution Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥293m |
| Medical Institution Support Businessreportable segment | employees | at 2025-03-31 | 0 pure |
| Medical Institution Support Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥286m |
| Medical Institution Support Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥286m |
| Medical Institution Support Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥95m |
| Health Management Cloud Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Health Management Cloud Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Health Management Cloud Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥594m |
| Medical Checkup Solution Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥11.9bn |
| Medical Checkup Solution Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥11.9bn |
| Medical Checkup Solution Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥276m |
| Medical Institution Support Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥303m |
| Medical Institution Support Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥303m |
| Medical Institution Support Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥97m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 780
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.050 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 201700 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.037 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 168900 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.031 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 70700 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.013 | |
| Number of shares held | CurrentYearInstant | 5448200 | |
| Shareholding ratio | CurrentYearInstant | 1.000 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 54482 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 5448200 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant | 5448200 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 54482 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 232910000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 42.75 | |
| Number of male directors and other officers | FilingDateInstant | 6 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000MatsudaYasuhideMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000SasakiMasayukiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000NamikiYoheiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000OnishiShoheiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000TakedaMasakoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000ItoShinyaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000SoshiYukariMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37743-000SatoTakayukiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | － | |
| Audit fees reporting company | Prior1YearDuration | 25000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | 1000000 | JPY |
| Audit fees reporting company | CurrentYearDuration | 25000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 63336000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 33900000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 23936000 | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 5500000 | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 2 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 26204000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |